PharmaShots | Incisive News in 3 Shots

Subscribe Now

Lung Disease

Roche's Actemra/RoActemra (tocilizumab) Receives the US FDA's Approval as the First Biologic for Systemic Sclerosis-Associated Interstitial Lung Disease

Roche's Actemra/RoActemra (tocilizumab) Receives the US FDA's Approval as the First Biologic for Systemic Sclerosis-Associated Int...

March 5, 2021

Genentech's Esbriet (pirfenidone) Receives FDA's Breakthrough Therapy Designation for Unclassifiable Interstitial Lung Disease

Genentech's Esbriet (pirfenidone) Receives FDA's Breakthrough Therapy Designation for Unclassifiable Interstitial Lung Disease

March 3, 2020

Boehringer Ingelheim's Nintedanib Receives CHMP's Positive Opinion to Treat Systemic Sclerosis-Associated Interstitial Lung Disease

Boehringer Ingelheim's Nintedanib Receives CHMP's Positive Opinion to Treat Systemic Sclerosis-Associated Interstitial Lung Diseas...

March 2, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us